The early-stage trial is assessing the safety and efficacy of the ipatasertib combination in patients with locally advanced or metastatic triple-negative breast cancer who previously did not receive
The post Roche’s ipatasertib combo yields promising results in Phase Ib breast cancer trial appeared first on Pharmaceutical Business review.